Provided by Tiger Trade Technology Pte. Ltd.

Nektar Therapeutics

75.06
+2.853.94%
Post-market: 75.490.4350+0.58%18:36 EDT
Volume:763.68K
Turnover:57.07M
Market Cap:2.15B
PE:-7.71
High:75.80
Open:73.42
Low:72.59
Close:72.21
52wk High:77.00
52wk Low:6.48
Shares:28.69M
Float Shares:26.24M
Volume Ratio:0.90
T/O Rate:2.91%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-9.7300
EPS(LYR):-8.6765
ROE:-217.94%
ROA:-27.98%
PB:23.97
PE(LYR):-8.65

Loading ...

Nektar Therapeutics Partners with UCSF to Study MS Antibody Therapy

Reuters
·
Feb 17

Nektar Therapeutics Announces Research Collaboration With Ucsf and DR. Stephen Hauser for Nktr-0165, a Tumor Necrosis Factor Receptor 2 (Tnfr2) Antibody, in Multiple Sclerosis

THOMSON REUTERS
·
Feb 17

Nektar Therapeutics Closes $460 Million Equity Offering

MT Newswires Live
·
Feb 14

BUZZ-U.S. STOCKS ON THE MOVE-FedEx Corp, Lincoln National

Reuters
·
Feb 13

BUZZ-Nektar Therapeutics eases after boosted $400 mln share sale

Reuters
·
Feb 12

BRIEF-Nektar Therapeutics Announces Pricing Of Upsized $400 Million Public Offering

Reuters
·
Feb 12

Nektar Therapeutics - Shares Sold at $58.00 per Share

THOMSON REUTERS
·
Feb 12

BUZZ-Nektar extends surge after promising eczema drug data

Reuters
·
Feb 11

U.S. RESEARCH ROUNDUP-Coca-Cola, Rapid7, Walmart

Reuters
·
Feb 11

Nektar Therapeutics : Btig Raises Target Price to $151 From $118

THOMSON REUTERS
·
Feb 11

Nektar Therapeutics Launches $300 Million Public Offering with Pre-Funded Warrants

Reuters
·
Feb 11

Nektar Therapeutics Announces Proposed Public Offering

THOMSON REUTERS
·
Feb 11

Nektar Therapeutics - Announces $300 Mln Public Offering

THOMSON REUTERS
·
Feb 11

Nektar Therapeutics Is Maintained at Buy by BTIG

Dow Jones
·
Feb 11

Nektar price target raised to $151 from $118 at BTIG

TIPRANKS
·
Feb 11

Nektar upgraded to Outperform from Market Perform at William Blair

TIPRANKS
·
Feb 11

Nektar Therapeutics : William Blair Raises to Outperform Rating

THOMSON REUTERS
·
Feb 11

BUZZ-U.S. STOCKS ON THE MOVE-Zimmer Biomet, Datadog​, Ecolab

Reuters
·
Feb 10

Nektar Therapeutics : H.c. Wainwright Raises Target Price to $165 From $135

THOMSON REUTERS
·
Feb 10

Nektar Therapeutics Rises on Positive Dermatitis Drug Data

Dow Jones
·
Feb 10